Michelle Boyer is currently the Interim Global Head of Lymphoma/CLL Clinical Development at Genentech, a position they began in 2023. Prior to this, they held various roles at Roche from 2020 to 2023, progressing from Global Development Leader to multiple positions in clinical development and regulatory documentation. Michelle earned their degree from Queen's University Belfast, where they studied from 2001 to 2005.
This person is not in any teams
This person is not in any offices